unknown
Stage
About
Illudent is developing a novel small molecule as a precision medicine for solid tumors.
Explore Illudent's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Illudent is developing a novel small molecule as a precision medicine for solid tumors.
Funding rounds, investor list, and risk signals — unlock with a subscription.